All the news that gives us fits to print

Vytorin Doesn’t Work

Filed under: Business,Health,Investment News — Tags: , , , , , , — Paddy Wallbouncer @ 9:31 am 2008 January 15

The popular cholesterol lowering drug Vytorin just doesn’t work. That’s according to the head of Cardiology at the prestigious Cleveland Clinic. Not a popular stand to take when a drug company has 5 billion in sales at stake.

Vytorin is a combination of two drugs, Ezetimibe and Simvastatin. Simvastatin is also known by the genric name Zocor, and costs much less than a dollar. Zocor appears to be the more beneficial ingredient in Vytorin. You’ll spend about three dollars for Vytorin.

Vytorin is a joint venture between Schering-Plough and Merck.. Shares of both were down yesterday, with Schering-Plough taking the brunt of the hit -8%. Michigan democrat Representative Bart Stupak is leading a congressional investigation into allegations that the drug companies knowingly withheld the results of the study in order to maximize their profit.

Four of five years ago it was rare to see a television commercial touting prescription drugs. An occasional magazine article for Claritin (before it was released generic in the early 2000’s) was the norm. Today, you cannot watch network TV for more than 10 minutes before you are presented with arguments about why you should get Viagra, Cialis, Vytorin or Crestor to name a few.

Drugs are big business, and they are becoming bigger business as their money extends into the more mainstream media outlets. If everybody had a financial stake in the success of a drug (Vytorin) for example, would the corporate machine run unfettered?

Facebook Comments

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.